• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺肿瘤微血管密度的异质性:与正常支气管的比较。

Heterogeneity in microvascular density in lung tumours: comparison with normal bronchus.

作者信息

Schor A M, Pazouki S, Morris J, Smither R L, Chandrachud L M, Pendleton N

机构信息

Cell and Molecular Biology Unit, Dental School, University of Dundee, UK.

出版信息

Br J Cancer. 1998 Mar;77(6):946-51. doi: 10.1038/bjc.1998.156.

DOI:10.1038/bjc.1998.156
PMID:9528839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2150091/
Abstract

The aim of this study was to test the hypotheses that (a) microvascular density (MVD) measured in histological sections of resected non-small cell lung carcinomas is an index of angiogenesis and (b) the measurement of MVD in a single block is representative of the overall MVD of the tumour. MVD was quantitated in one block per specimen of 60 lung tumours and nine normal lung tissues, and in 47 blocks taken from different regions of four tumours. Blood vessels were stained with antibody to von Willebrand Factor and MVD was quantitated using two methods: average density throughout the section (a-MVD) and density in the most vascularized area or 'hot spot' (h-MVD). Similar h-MVD values were found in tumours and in normal bronchus, whereas a-MVD was greater in the latter (P < 0.01). When 47 blocks from four tumours were analysed, inter-tumour variation was significant (P < 0.001) in spite of significant intra-tumour variation. The highest MVD value was not necessarily found in the periphery of the tumour. The four tumours were ranked into either two or four tiers according to their overall MVD. In 50 random selections of one block per tumour, the correct ranking was achieved in 68-74% of cases with the two-tier ranking and in 6-16% of cases with the four-tier ranking (h-MVD and a-MVD values respectively). These results suggest that elevated MVD values do not necessarily represent angiogenesis in non-small cell lung carcinomas. When only one block per tumour is examined, the chance of obtaining an accurate estimate of the vascularity of that tumour may be lower than 68%.

摘要

本研究的目的是检验以下假设

(a) 在切除的非小细胞肺癌组织切片中测量的微血管密度(MVD)是血管生成的一个指标;(b) 在单个组织块中测量的MVD代表肿瘤的整体MVD。对60个肺肿瘤标本和9个正常肺组织的每个标本中的一个组织块进行MVD定量,并对取自4个肿瘤不同区域的47个组织块进行MVD定量。用抗血管性血友病因子抗体对血管进行染色,并使用两种方法对MVD进行定量:整个切片的平均密度(a-MVD)和血管最丰富区域或“热点”的密度(h-MVD)。在肿瘤和正常支气管中发现了相似的h-MVD值,而后者的a-MVD更高(P<0.01)。当对来自4个肿瘤的47个组织块进行分析时,尽管肿瘤内存在显著差异,但肿瘤间差异仍具有显著性(P<0.001)。最高的MVD值不一定出现在肿瘤周边。根据整体MVD将这4个肿瘤分为两级或四级。在每个肿瘤随机选择一个组织块的50次抽样中,两级分级时68%-74%的病例获得了正确分级,四级分级时6%-16%的病例获得了正确分级(分别为h-MVD和a-MVD值)。这些结果表明,升高的MVD值不一定代表非小细胞肺癌中的血管生成。当每个肿瘤仅检查一个组织块时,准确估计该肿瘤血管情况的可能性可能低于68%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ee/2150091/fa9bd10048e2/brjcancer00082-0097-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ee/2150091/fa9bd10048e2/brjcancer00082-0097-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ee/2150091/fa9bd10048e2/brjcancer00082-0097-a.jpg

相似文献

1
Heterogeneity in microvascular density in lung tumours: comparison with normal bronchus.肺肿瘤微血管密度的异质性:与正常支气管的比较。
Br J Cancer. 1998 Mar;77(6):946-51. doi: 10.1038/bjc.1998.156.
2
Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung.肺腺癌和肺鳞状细胞癌中肿瘤血管生成的免疫组织化学评估
Rocz Akad Med Bialymst. 1997;42 Suppl 1:271-9.
3
Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.非小细胞肺癌患者循环内皮祖细胞数量和肿瘤内微血管密度:腺癌组织学亚型之间血管生成状态的差异。
J Thorac Oncol. 2012 Mar;7(3):503-11. doi: 10.1097/JTO.0b013e318241780e.
4
Prognostic significance of microvascularization in cases of operated lung cancer.手术治疗的肺癌病例中微血管形成的预后意义
Eur J Cardiothorac Surg. 2005 Jun;27(6):1106-11. doi: 10.1016/j.ejcts.2005.01.036. Epub 2005 Mar 2.
5
Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer.人体宫颈癌中宿主组织血管生成与具有预后相关性的肿瘤血管生成之间的关联。
Int J Oncol. 2001 Oct;19(4):827-32.
6
Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage.关于肺癌血管生成强度与肿瘤组织学类型及临床分期相关性的研究。
Rocz Akad Med Bialymst. 1997;42 Suppl 1:254-70.
7
Angiogenesis and mast cell density as predictors of patient survival in squamous cell carcinoma of lung.血管生成和肥大细胞密度作为肺鳞状细胞癌患者生存的预测指标
J Cancer Res Ther. 2013 Oct-Dec;9(4):701-5. doi: 10.4103/0973-1482.126487.
8
Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.非小细胞肺癌中血管内皮生长因子的表达与新生血管形成
Int J Surg Pathol. 2009 Oct;17(5):390-5. doi: 10.1177/1066896908323506. Epub 2008 Oct 10.
9
The association between tumour progression and vascularity in the oral mucosa.口腔黏膜中肿瘤进展与血管形成之间的关联。
J Pathol. 1997 Sep;183(1):39-43. doi: 10.1002/(SICI)1096-9896(199709)183:1<39::AID-PATH1088>3.0.CO;2-L.
10
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.血管内皮生长因子(VEGF)及其两种受体(VEGF-R1-Flt1和VEGF-R2-Flk1/KDR)在非小细胞肺癌(NSCLC)中的表达:与血管生成和生存的相关性
J Pathol. 1999 Aug;188(4):369-77. doi: 10.1002/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X.

引用本文的文献

1
Predictive value of F-FDG PET/CT multi-metabolic parameters and tumor metabolic heterogeneity in the prognosis of gastric cancer.18F-FDG PET/CT 多代谢参数及肿瘤代谢异质性对胃癌预后的预测价值。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14535-14547. doi: 10.1007/s00432-023-05246-4. Epub 2023 Aug 12.
2
Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer.肺癌联合化疗的药代动力学/药效学模型。
J Theor Biol. 2018 Jul 7;448:38-52. doi: 10.1016/j.jtbi.2018.03.035. Epub 2018 Apr 1.
3
A review of the development of tumor vasculature and its effects on the tumor microenvironment.

本文引用的文献

1
Relationship between vascularity, age and survival in non-small-cell lung cancer.
Br J Cancer. 1997;76(10):1367-75. doi: 10.1038/bjc.1997.562.
2
The association between tumour progression and vascularity in the oral mucosa.口腔黏膜中肿瘤进展与血管形成之间的关联。
J Pathol. 1997 Sep;183(1):39-43. doi: 10.1002/(SICI)1096-9896(199709)183:1<39::AID-PATH1088>3.0.CO;2-L.
3
Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast.肿瘤血管生成作为乳腺浸润性小叶癌的预后标志物
肿瘤血管生成的发展及其对肿瘤微环境的影响综述。
Hypoxia (Auckl). 2017 Apr 11;5:21-32. doi: 10.2147/HP.S133231. eCollection 2017.
4
Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas.微血管密度与人类胃肠道癌不同区域的 VEGF 和 α-SMA 表达相关。
Cancers (Basel). 2011 Aug 31;3(3):3405-18. doi: 10.3390/cancers3033405.
5
Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.利用动态对比增强磁共振成像量化肿瘤血管异质性:综述
J Biomed Biotechnol. 2011;2011:732848. doi: 10.1155/2011/732848. Epub 2011 Apr 26.
6
Clinical biomarkers of angiogenesis inhibition.血管生成抑制的临床生物标志物。
Cancer Metastasis Rev. 2008 Sep;27(3):415-34. doi: 10.1007/s10555-008-9143-x.
7
A three-dimensional analysis of blood vessels in bronchioloalveolar carcinoma.细支气管肺泡癌中血管的三维分析
Lung. 2004;182(6):343-53. doi: 10.1007/s00408-004-2515-2.
8
Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer.血管生成及血管内皮生长因子表达在非小细胞肺癌中的预后价值
J Clin Pathol. 2001 Feb;54(2):116-20. doi: 10.1136/jcp.54.2.116.
9
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.血管内皮生长因子、血小板衍生内皮细胞生长因子与非小细胞肺癌中的血管生成
Br J Cancer. 2000 Apr;82(8):1427-32. doi: 10.1054/bjoc.1999.1129.
10
Assessment of vascularity in histological sections: effects of methodology and value as an index of angiogenesis in breast tumours.组织学切片中血管分布的评估:方法学的影响及其作为乳腺肿瘤血管生成指标的价值
Histochem J. 1998 Dec;30(12):849-56. doi: 10.1023/a:1003437619956.
J Pathol. 1996 Sep;180(1):44-9. doi: 10.1002/(SICI)1096-9896(199609)180:1<44::AID-PATH648>3.0.CO;2-C.
4
Neovascularization in hyperplastic, metaplastic and potentially preneoplastic lesions of the bronchial mucosa.支气管黏膜增生性、化生及潜在癌前病变中的新生血管形成。
Virchows Arch. 1996 Oct;429(2-3):95-100. doi: 10.1007/BF00192431.
5
Tumor angiogenesis in human lung adenocarcinoma.
Cancer. 1995 Jul 1;76(1):151. doi: 10.1002/1097-0142(19950701)76:1<151::aid-cncr2820760123>3.0.co;2-d.
6
Heterogeneity and reproducibility of microvessel counts in breast cancer.乳腺癌中微血管计数的异质性和可重复性
Lab Invest. 1995 Dec;73(6):922-6.
7
Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis.乳腺癌血管生成的定量分析及预后价值:微血管密度、Chalkley计数与计算机图像分析的比较
J Pathol. 1995 Nov;177(3):275-83. doi: 10.1002/path.1711770310.
8
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer.评估肿瘤血管生成作为淋巴结阴性浸润性乳腺癌的一个预后因素。
Eur J Cancer. 1993;29A(8):1141-5. doi: 10.1016/s0959-8049(05)80304-1.
9
Angiogenesis in invasive squamous cell carcinoma of the lip: tumor vascularity is not an indicator of metastatic risk.
J Cutan Pathol. 1995 Jun;22(3):236-40. doi: 10.1111/j.1600-0560.1995.tb00744.x.
10
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.膀胱癌中的血管生成:微血管密度与肿瘤预后的关系。
J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12. doi: 10.1093/jnci/87.21.1603.